InsidersTradesSigma
클래시스 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 클래시스 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 클래시스 has recorded 9 public disclosures. Market capitalisation: €2,670.7bn. The latest transaction was filed on 13 March 2026 (Other). Among the most active insiders: BCPECenturInvestments,LP. All data is accessible without an account.
9
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
4 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 클래시스 Buy (bullish), based on 19 analysts. Average price target: ₩73,105.
2Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,143 of 27,989 companies
72.7
score / 100
Value56
Quality89
FCF yld5.4%
Earn yld4.9%
EV/EBITDA14.8x
ROE27%
Gross mgn78%
Net mgn39%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 13 March 2026
Declarations9 total
ShareKRXDART:20260227000927
4,019,400 sharesKRXDART:20260226001381
5,532,987 sharesKRXDART:20260226001437
866,036 sharesKRXDART:20241010000540
ShareKRXDART:20221117000218
9 of 9 declarations
About 클래시스
클래시스 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in developing innovative solutions for the medical sector.